Filter
2941
Text search:
essential
drug
list
Featured
Recommendations
316
New Publications
887
Language
Document type
No document type
1713
Guidelines
446
Studies & Reports
397
Manuals
179
Strategic & Response Plan
108
Training Material
58
Fact sheets
21
Situation Updates
9
Brochures
4
Resource Platforms
2
Online Courses
2
Infographics
1
Countries / Regions
India
197
Kenya
98
Global
95
Ethiopia
92
South Africa
85
Nigeria
78
Uganda
75
Sierra Leone
66
Nepal
60
Liberia
54
Tanzania
53
Ghana
49
Malawi
49
Zambia
45
Bangladesh
45
Africa
43
Myanmar / Burma
42
Western and Central Europe
39
Latin America and the Carribbean
38
Namibia
36
Rwanda
31
Philippines
24
South–East Asia Region
22
Asia
21
Zimbabwe
19
Cambodia
19
Botswana
19
Lesotho
19
Ukraine
17
Syria
16
Eswatini/ Swaziland
15
Eastern Europe
15
Mozambique
11
Burkina Faso
10
Senegal
10
Indonesia
10
Haiti
9
Thailand
8
West and Central Africa
8
Cameroon
7
Germany
7
East and Southern Africa
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Congo, Democratic Republic of
6
Pakistan
6
South Sudan
6
Brazil
6
Western Pacific Region
6
Russia
6
Guinea
5
USA
5
China
5
Sudan
5
Venezuela
5
Laos
5
Vietnam
5
Benin
4
Albania
4
Tajikistan
4
North America
4
Iraq
3
Afghanistan
3
Central African Republic
3
North Macedonia
3
Colombia
3
Mexico
3
Sri Lanka
3
Fiji
3
Timor Leste/ East Timor
3
Kyrgyzstan
3
Georgia
3
Jamaica
3
Jordan
2
Papua New Guinea
2
Argentina
2
Peru
2
Hungary
2
Libya
2
Bhutan
2
Canada
2
Moldova
2
Iran
2
Kazakhstan
2
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Somalia
1
Lebanon
1
Turkey
1
Egypt
1
Switzerland
1
Serbia
1
Honduras
1
El Salvador
1
Bolivia
1
Angola
1
Guatemala
1
Madagascar
1
Nicaragua
1
Chile
1
Yemen
1
Paraguay
1
Solomon Islands
1
Poland
1
North Korea
1
Armenia
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Australia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1259
Clinical Guidelines
284
Public Health
154
Women & Child Health
132
Key Resources
119
Capacity Building
57
Pharmacy & Technologies
46
Annual Report MEDBOX
1
Toolboxes
HIV
259
Mental Health
234
TB
214
AMR
191
Pharmacy
139
NTDs
97
COVID-19
95
Caregiver
84
NCDs
58
Malaria
51
Conflict
43
Rapid Response
43
Ebola & Marburg
38
Disability
32
Planetary Health
32
Global Health Education
29
Refugee
28
Health Financing Toolbox
20
2.0 Rapid Response
20
Cholera
13
Specific Hazards
13
Natural Hazards
11
Polio
10
Zika
6
Social Ethics
4
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this
...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of
...
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance.
...
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug
...